Dataset Information

Complete Genome Sequence of Bacillus paralicheniformis 14DA11, Exhibiting Resistance to Clindamycin and Erythromycin.

ABSTRACT: Bacillus paralicheniformis 14DA11, exhibiting resistance to clindamycin and erythromycin, was isolated from a Korean fermented soybean food product. The complete genome of strain 14DA11 includes genes that potentially contribute to the antibiotic resistance.

SUBMITTER: Lee JH

PROVIDER: S-EPMC5658509 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Complete Genome Sequence of <i>Bacillus paralicheniformis</i> 14DA11, Exhibiting Resistance to Clindamycin and Erythromycin.

Lee Jong-Hoon JH Jeong Do-Won DW

Genome announcements 20171026 43

<i>Bacillus paralicheniformis</i> 14DA11, exhibiting resistance to clindamycin and erythromycin, was isolated from a Korean fermented soybean food product. The complete genome of strain 14DA11 includes genes that potentially contribute to the antibiotic resistance. ...[more]

PMID: 29074671

Similar Datasets

Project description:Bifidobacteria are mutualistic intestinal bacteria, and their presence in the human gut has been associated with health-promoting activities. The presence of antibiotic resistance genes in this genus is controversial, since, although bifidobacteria are nonpathogenic microorganisms, they could serve as reservoirs of resistance determinants for intestinal pathogens. However, until now, few antibiotic resistance determinants have been functionally characterized in this genus. In this work, we show that Bifidobacterium breve CECT7263 displays atypical resistance to erythromycin and clindamycin. In order to delimit the genomic region responsible for the observed resistance phenotype, a library of genomic DNA was constructed and a fragment of 5.8 kb containing a gene homologous to rRNA methylase genes was able to confer erythromycin resistance in Escherichia coli This genomic region seems to be very uncommon, and homologs of the gene have been detected in only one strain of Bifidobacterium longum and two other strains of B. breve In this context, analysis of shotgun metagenomics data sets revealed that the gene is also uncommon in the microbiomes of adults and infants. The structural gene and its upstream region were cloned into a B. breve-sensitive strain, which became resistant after acquiring the genetic material. In vitro conjugation experiments did not allow us to detect gene transfer to other recipients. Nevertheless, prediction of genes potentially acquired through horizontal gene transfer events revealed that the gene is located in a putative genomic island.IMPORTANCEBifidobacterium breve is a very common human intestinal bacterium. Often described as a pioneer microorganism in the establishment of early-life intestinal microbiota, its presence has been associated with several beneficial effects for the host, including immune stimulation and protection against infections. Therefore, some strains of this species are considered probiotics. In relation to this, because probiotic bacteria are used for human and animal consumption, one of the safety concerns over these bacteria is the presence of antibiotic resistance genes, since the human gut is a densely populated habitat that could favor the transfer of genetic material to potential pathogens. In this study, we analyzed the genetic basis responsible for the erythromycin and clindamycin resistance phenotype of B. breve CECT7263. We were able to identify and characterize a novel gene homologous to rRNA methylase genes which confers erythromycin and clindamycin resistance. This gene seems to be very uncommon in other bifidobacteria and in the gut microbiomes of both adults and infants. Even though conjugation experiments showed the absence of transferability under in vitro conditions, it has been predicted to be located in a putative genomic island recently acquired by specific bifidobacterial strains.

Dataset Information

Complete Genome Sequence of Bacillus paralicheniformis 14DA11, Exhibiting Resistance to Clindamycin and Erythromycin.

Publications

Complete Genome Sequence of <i>Bacillus paralicheniformis</i> 14DA11, Exhibiting Resistance to Clindamycin and Erythromycin.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets